Join a free Medicare Part D workshop to learn about coverage options and significant industry changes affecting health services. Compare plans for savings!

Aetna improves cancer treatment preapproval, enhancing efficiency and reducing burdens for providers. Learn how this impacts healthcare delivery and insurance.

Explore the implications of Dana-Farber's removal from Medicare Advantage plans, highlighting patient choices and future healthcare developments. Act now!

Explore the disparities in multiple myeloma treatment initiation between Medicare Advantage and Traditional Medicare, revealing critical impacts on patient access.

Explore the impact of new Medicare laws on cancer detection and care, emphasizing advancements in screening technologies for better patient outcomes.

Explore the financial challenges faced by cancer patients with insurance coverage; many incur significant medical debt despite health insurance limits.

Explore the financial impact of cancer treatment post-ACA, highlighting cost reductions and ongoing burdens on families seeking insurance access.

Explore the financial challenges faced by cancer survivors and the impact of health insurance on their healthcare choices. Essential reading for stakeholders.

Pennsylvania Senate Bill 1211 ensures health insurance covers biomarker tests for cancer and ALS, improving access to personalized treatments for patients statewide.

ACS CAN warns that proposed ACA changes may harm patient protections and access to cancer care. Urgent action needed to protect healthcare access.